Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir.

Abstract:

BACKGROUND:HIV infection and antiretroviral treatment are associated with changes in lipid levels, insulin resistance and risk of cardiovascular disease (CVD). We investigated these changes in the first 96 weeks of treatment with low-dose stavudine or tenofovir regimens. METHODS:This is a secondary analysis of a double blind, randomised controlled trial performed in South-Africa, Uganda and India comparing low-dose stavudine (20 mg twice daily) with tenofovir in combination with efavirenz and lamivudine in antiretroviral-naïve adults (n = 1067) (Clinicaltrials.gov, NCT02670772). Over 96 weeks, data were collected on fasting lipids, glucose and insulin. Insulin resistance was assessed with the HOMA-IR index and 10-year CVD risk with the Framingham risk score (FRS). A generalized linear mixed model was used to estimate trends over time. RESULTS:Participants were on average 35.3 years old, 57.6% female and 91.8% Black African. All lipid levels increased following treatment initiation, with the sharpest increase in the first 24 weeks of treatment. The increase in all lipid subcomponents over 96 weeks was higher among those in the stavudine than the tenofovir group. Insulin resistance increased steadily with no difference detected between study groups. FRS rose from 1.90% (1.84-1.98%) at baseline to 2.06 (1.98-2.15%) at week 96 for the total group, with no difference between treatment arms (p = 0.144). Lipid changes were more marked in Indian than African participants. CONCLUSION:Lipid levels increased in both groups, with low-dose stavudine resulting in a worse lipid profile compared to tenofovir. Insulin resistance increased, with no difference between regimens. CVD risk increased over time and tended to increase more in the group on stavudine. The low CVD risk across both arms argues against routine lipid and glucose monitoring in the absence of other CVD risk factors. In high risk patients, monitoring may only be appropriate at least a year after treatment initiation.

journal_name

Retrovirology

journal_title

Retrovirology

authors

Vos AG,Chersich MF,Klipstein-Grobusch K,Zuithoff P,Moorhouse MA,Lalla-Edward ST,Kambugu A,Kumarasamy N,Grobbee DE,Barth RE,Venter WD

doi

10.1186/s12977-018-0460-z

subject

Has Abstract

pub_date

2018-12-14 00:00:00

pages

77

issue

1

issn

1742-4690

pii

10.1186/s12977-018-0460-z

journal_volume

15

pub_type

杂志文章,随机对照试验
  • Digital PCR as a tool to measure HIV persistence.

    abstract::Although antiretroviral therapy is able to suppress HIV replication in infected patients, the virus persists and rebounds when treatment is stopped. In order to find a cure that can eradicate the latent reservoir, one must be able to quantify the persisting virus. Traditionally, HIV persistence studies have used real-...

    journal_title:Retrovirology

    pub_type: 杂志文章,评审

    doi:10.1186/s12977-018-0399-0

    authors: Rutsaert S,Bosman K,Trypsteen W,Nijhuis M,Vandekerckhove L

    更新日期:2018-01-30 00:00:00

  • Identification of small molecule modulators of HIV-1 Tat and Rev protein accumulation.

    abstract:BACKGROUND:HIV-1 replication is critically dependent upon controlled processing of its RNA and the activities provided by its encoded regulatory factors Tat and Rev. A screen of small molecule modulators of RNA processing identified several which inhibited virus gene expression, affecting both relative abundance of spe...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-017-0330-0

    authors: Balachandran A,Wong R,Stoilov P,Pan S,Blencowe B,Cheung P,Harrigan PR,Cochrane A

    更新日期:2017-01-26 00:00:00

  • How to engage Cofilin.

    abstract::In HIV-infected people, resting CD4+ T cells are the main reservoir of latent virus and the reason for the failure of drug therapy to cure HIV infection. Still, we do not have a complete understanding of the factors regulating HIV replication in these cells. A recent paper in Cell describes a new trick that the virus ...

    journal_title:Retrovirology

    pub_type: 杂志文章,评审

    doi:10.1186/1742-4690-5-85

    authors: Bukrinsky M

    更新日期:2008-09-22 00:00:00

  • Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks.

    abstract:BACKGROUND:We have previously reported that CD4 T cells from some exposed uninfected (EU) Vietnamese intravenous drug users are relatively resistant to HIV infection in vitro. Here, we further characterized the restriction of viral replication in CD4 T cells from five EUs and assessed its persistence in serial samples....

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-3-81

    authors: Sáez-Cirión A,Versmisse P,Truong LX,Chakrabarti LA,Carpentier W,Barré-Sinoussi F,Scott-Algara D,Pancino G

    更新日期:2006-11-08 00:00:00

  • The co-receptor signaling model of HIV-1 pathogenesis in peripheral CD4 T cells.

    abstract::HIV-mediated CD4 depletion is the hallmark of AIDS and is the most reliable predictor of disease progression. While HIV replication is associated with CD4 depletion in general, plasma viremia by itself predicts the rate of CD4 loss only minimally in untreated patients. To resolve this paradox, I hypothesize the existe...

    journal_title:Retrovirology

    pub_type: 社论

    doi:10.1186/1742-4690-6-41

    authors: Wu Y

    更新日期:2009-05-01 00:00:00

  • HIV-1 Vif, APOBEC, and intrinsic immunity.

    abstract::Members of the APOBEC family of cellular cytidine deaminases represent a recently identified group of proteins that provide immunity to infection by retroviruses and protect the cell from endogenous mobile retroelements. Yet, HIV-1 is largely immune to the intrinsic antiviral effects of APOBEC proteins because it enco...

    journal_title:Retrovirology

    pub_type: 杂志文章,评审

    doi:10.1186/1742-4690-5-51

    authors: Goila-Gaur R,Strebel K

    更新日期:2008-06-24 00:00:00

  • Limited cross-border infections in patients newly diagnosed with HIV in Europe.

    abstract:BACKGROUND:International travel plays a role in the spread of HIV-1 across Europe. It is, however, not known whether international travel is more important for spread of the epidemic as compared to endogenous infections within single countries. In this study, phylogenetic associations among HIV of newly diagnosed patie...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-10-36

    authors: Frentz D,Wensing AM,Albert J,Paraskevis D,Abecasis AB,Hamouda O,Jørgensen LB,Kücherer C,Struck D,Schmit JC,Åsjö B,Balotta C,Beshkov D,Camacho RJ,Clotet B,Coughlan S,De Wit S,Griskevicius A,Grossman Z,Horban A,Kolu

    更新日期:2013-04-03 00:00:00

  • Preferences for the selection of unique tRNA primers revealed from analysis of HIV-1 replication in peripheral blood mononuclear cells.

    abstract:BACKGROUND:All human immunodeficiency virus (HIV-1) uses a host tRNALys,3 as the primer for reverse transcription. The tRNALys,3 is bound to a region on the HIV-1 genome, the primer-binding site (PBS), that is complementary to the 18 terminal nucleotides of tRNALys,3. How HIV-1 selects the tRNA from the intracellular m...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-2-21

    authors: Moore-Rigdon KL,Kosloff BR,Kirkman RL,Morrow CD

    更新日期:2005-03-24 00:00:00

  • A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants.

    abstract:BACKGROUND:The recently approved anti-AIDS drug rilpivirine (TMC278, Edurant) is a nonnucleoside inhibitor (NNRTI) that binds to reverse transcriptase (RT) and allosterically blocks the chemical step of DNA synthesis. In contrast to earlier NNRTIs, rilpivirine retains potency against well-characterized, clinically rele...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-9-99

    authors: Johnson BC,Pauly GT,Rai G,Patel D,Bauman JD,Baker HL,Das K,Schneider JP,Maloney DJ,Arnold E,Thomas CJ,Hughes SH

    更新日期:2012-12-05 00:00:00

  • TLR2 and TLR4 triggering exerts contrasting effects with regard to HIV-1 infection of human dendritic cells and subsequent virus transfer to CD4+ T cells.

    abstract:BACKGROUND:Recognition of microbial products through Toll-like receptors (TLRs) initiates inflammatory responses orchestrated by innate immune cells such as dendritic cells (DCs). As these cells are patrolling mucosal surfaces, a portal of entry for various pathogens including human immunodeficiency virus type-1 (HIV-1...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-6-42

    authors: Thibault S,Fromentin R,Tardif MR,Tremblay MJ

    更新日期:2009-05-06 00:00:00

  • HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.

    abstract:BACKGROUND:Human T-cell lymphotropic virus type 1 (HTLV-1) is the etiological agent of HTLV associated myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) and Adult T cell leukemia/lymphoma (ATLL), in around 2-5% of the infected individuals. Host genetic background might play a role in disease progression. Several previ...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-020-00536-y

    authors: Benencio P,Fraile Gonzalez SA,Ducasa N,Page K,Berini CA,Biglione MM

    更新日期:2020-09-03 00:00:00

  • World AIDS Day 2007: AIDS at 26, are we there yet?

    abstract::This editorial comments on selected progress made in combating the acquired immune deficiency syndrome (AIDS) after 26 years and some of the remaining challenges. ...

    journal_title:Retrovirology

    pub_type: 社论

    doi:10.1186/1742-4690-4-86

    authors: Jeang KT

    更新日期:2007-12-01 00:00:00

  • MDM2 is a novel E3 ligase for HIV-1 Vif.

    abstract::The human immunodeficiency virus type 1 (HIV-1) Vif plays a crucial role in the viral life cycle by antagonizing a host restriction factor APOBEC3G (A3G). Vif interacts with A3G and induces its polyubiquitination and subsequent degradation via the formation of active ubiquitin ligase (E3) complex with Cullin5-ElonginB...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-6-1

    authors: Izumi T,Takaori-Kondo A,Shirakawa K,Higashitsuji H,Itoh K,Io K,Matsui M,Iwai K,Kondoh H,Sato T,Tomonaga M,Ikeda S,Akari H,Koyanagi Y,Fujita J,Uchiyama T

    更新日期:2009-01-07 00:00:00

  • Host mRNA decay proteins influence HIV-1 replication and viral gene expression in primary monocyte-derived macrophages.

    abstract:BACKGROUND:Mammalian cells harbour RNA quality control and degradative machineries such as nonsense-mediated mRNA decay that target cellular mRNAs for clearance from the cell to avoid aberrant gene expression. The role of the host mRNA decay pathways in macrophages in the context of human immunodeficiency virus type 1 ...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-019-0465-2

    authors: Rao S,Amorim R,Niu M,Breton Y,Tremblay MJ,Mouland AJ

    更新日期:2019-02-07 00:00:00

  • Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibody.

    abstract:BACKGROUND:In the acute phase of infection with feline immunodeficiency virus (FIV), the virus targets activated CD4+ T cells by utilising CD134 (OX40) as a primary attachment receptor and CXCR4 as a co-receptor. The nature of the virus-receptor interaction varies between isolates; strains such as GL8 and CPGammer reco...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-7-38

    authors: Willett BJ,Kraase M,Logan N,McMonagle EL,Samman A,Hosie MJ

    更新日期:2010-04-26 00:00:00

  • Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?

    abstract::HIV viruses encode a set of accessory proteins, which are important determinants of virulence due to their ability to manipulate the host cell physiology for the benefit of the virus. Although these viral proteins are dispensable for viral growth in many in vitro cell culture systems, they influence the efficiency of ...

    journal_title:Retrovirology

    pub_type: 杂志文章,评审

    doi:10.1186/1742-4690-7-35

    authors: Ayinde D,Maudet C,Transy C,Margottin-Goguet F

    更新日期:2010-04-09 00:00:00

  • Emv2, the only endogenous ecotropic murine leukemia virus of C57BL/6J mice.

    abstract::With the proliferation of sequence data, great challenges are posed in the correct annotation of endogenous retroviruses, which together comprise up to ten per cent of the genomes of many organisms. It is therefore essential that all sources of information are carefully considered before drawing conclusions concerning...

    journal_title:Retrovirology

    pub_type: 评论,信件

    doi:10.1186/1742-4690-9-23

    authors: Young GR,Kassiotis G,Stoye JP

    更新日期:2012-03-22 00:00:00

  • Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics.

    abstract::Susceptibility to HIV-1 and the clinical course after infection show a substantial heterogeneity between individuals. Part of this variability can be attributed to host genetic variation. Initial candidate gene studies have revealed interesting host factors that influence HIV infection, replication and pathogenesis. R...

    journal_title:Retrovirology

    pub_type: 杂志文章,评审

    doi:10.1186/1742-4690-9-70

    authors: van Manen D,van 't Wout AB,Schuitemaker H

    更新日期:2012-08-24 00:00:00

  • Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP.

    abstract:BACKGROUND:Among human T cell leukemia virus type 1 (HTLV-1)-infected individuals, there is an association between HTLV-1 tax subgroups (subgroup-A or subgroup-B) and the risk of HAM/TSP in the Japanese population. To investigate the role of HTLV-1 subgroups in viral pathogenesis, we studied the functional difference i...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-018-0454-x

    authors: Naito T,Yasunaga JI,Mitobe Y,Shirai K,Sejima H,Ushirogawa H,Tanaka Y,Nakamura T,Hanada K,Fujii M,Matsuoka M,Saito M

    更新日期:2018-11-06 00:00:00

  • Moving beyond the mousetrap: current and emerging humanized mouse and rat models for investigating prevention and cure strategies against HIV infection and associated pathologies.

    abstract::The development of safe and effective combination antiretroviral therapies for human immunodeficiency virus (HIV) infection over the past several decades has significantly reduced HIV-associated morbidity and mortality. Additionally, antiretroviral drugs have provided an effective means of protection against HIV trans...

    journal_title:Retrovirology

    pub_type: 杂志文章,评审

    doi:10.1186/s12977-020-00515-3

    authors: Agarwal Y,Beatty C,Biradar S,Castronova I,Ho S,Melody K,Bility MT

    更新日期:2020-04-10 00:00:00

  • The expanding role of Tax in transcription.

    abstract::The viral transactivator of HTLV-I, Tax, has long been shown to target the earliest steps of transcription by forming quaternary complexes with sequence specific transcription factors and histone-modifying enzymes in the LTR of HTLV-I. However, a new study suggests that Tax preferentially transactivates the 21-bp repe...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-1-19

    authors: de la Fuente C,Kashanchi F

    更新日期:2004-07-30 00:00:00

  • Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication.

    abstract:BACKGROUND:Existing highly active antiretroviral therapy (HAART) effectively controls viral replication in human immunodeficiency virus type 1 (HIV-1) infected individuals but cannot completely eradicate the infection, at least in part due to the persistence of latently infected cells. One strategy that is being active...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-10-120

    authors: Miller LK,Kobayashi Y,Chen CC,Russnak TA,Ron Y,Dougherty JP

    更新日期:2013-10-24 00:00:00

  • Generation and validation of a highly sensitive bioluminescent HIV-1 reporter vector that simplifies measurement of virus release.

    abstract:BACKGROUND:The continued persistence of HIV-1 as a public health concern due to the lack of a cure calls for the development of new tools for studying replication of the virus. Here, we used NanoLuc, a small and extremely bright luciferase protein, to develop an HIV-1 bioluminescent reporter virus that simplifies funct...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-020-00521-5

    authors: Kirui J,Freed EO

    更新日期:2020-05-19 00:00:00

  • Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal.

    abstract:BACKGROUND:We reported previously that while prolonged tenofovir monotherapy of macaques infected with virulent simian immunodeficiency virus (SIV) resulted invariably in the emergence of viral mutants with reduced in vitro drug susceptibility and a K65R mutation in reverse transcriptase, some animals controlled virus ...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-9-57

    authors: Van Rompay KK,Trott KA,Jayashankar K,Geng Y,LaBranche CC,Johnson JA,Landucci G,Lipscomb J,Tarara RP,Canfield DR,Heneine W,Forthal DN,Montefiori D,Abel K

    更新日期:2012-07-17 00:00:00

  • Efficient trapping of HIV-1 envelope protein by hetero-oligomerization with an N-helix chimera.

    abstract:BACKGROUND:The N-heptad repeat region of the HIV-1 Transmembrane Envelope protein is a trimerization domain that forms part of a "six helix bundle" crucial to Envelope-mediated membrane fusion. N-heptad repeat peptides have been used as extracellular reagents to inhibit virus fusion. RESULTS:When expressed intracellul...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-2-51

    authors: Ou W,Silver J

    更新日期:2005-08-10 00:00:00

  • An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data.

    abstract:BACKGROUND:Entry of human immunodeficiency virus type 1 (HIV-1) into the host cell involves interactions between the viral envelope glycoproteins (Env) and the cellular receptor CD4 as well as a coreceptor molecule (most importantly CCR5 or CXCR4). Viral preference for a specific coreceptor (tropism) is in particular d...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-9-60

    authors: Bozek K,Eckhardt M,Sierra S,Anders M,Kaiser R,Kräusslich HG,Müller B,Lengauer T

    更新日期:2012-07-25 00:00:00

  • Physiological properties of astroglial cell lines derived from mice with high (SAMP8) and low (SAMR1, ICR) levels of endogenous retrovirus.

    abstract::Previous studies have reported that various inbred SAM mouse strains differ markedly with regard to a variety of parameters, such as capacity for learning and memory, life spans and brain histopathology. A potential cause of differences seen in these strains may be based on the fact that some strains have a high conce...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-5-104

    authors: Kim BH,Meeker HC,Shin HY,Kim JI,Jeong BH,Choi EK,Carp RI,Kim YS

    更新日期:2008-11-25 00:00:00

  • The distribution of insertionally polymorphic endogenous retroviruses in breast cancer patients and cancer-free controls.

    abstract:BACKGROUND:Integration of retroviral DNA into a germ cell can result in a provirus that is transmitted vertically to the host's offspring. In humans, such endogenous retroviruses (HERVs) comprise >8% of the genome. The HERV-K(HML-2) proviruses consist of ~90 elements related to mouse mammary tumor virus, which causes b...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-014-0062-3

    authors: Wildschutte JH,Ram D,Subramanian R,Stevens VL,Coffin JM

    更新日期:2014-08-12 00:00:00

  • Discovery of a diaminoquinoxaline benzenesulfonamide antagonist of HIV-1 Nef function using a yeast-based phenotypic screen.

    abstract:BACKGROUND:HIV-1 Nef is a viral accessory protein critical for AIDS progression. Nef lacks intrinsic catalytic activity and binds multiple host cell signaling proteins, including Hck and other Src-family tyrosine kinases. Nef binding induces constitutive Hck activation that may contribute to HIV pathogenesis by promoti...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-10-135

    authors: Trible RP,Narute P,Emert-Sedlak LA,Alvarado JJ,Atkins K,Thomas L,Kodama T,Yanamala N,Korotchenko V,Day BW,Thomas G,Smithgall TE

    更新日期:2013-11-14 00:00:00

  • Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model.

    abstract::It is well established that CD4(+) T cells play an important role in immunity to infections with retroviruses such as HIV. However, in recent years CD4(+) T cells have been subdivided into several distinct populations that are differentially regulated and perform widely varying functions. Thus, it is important to deli...

    journal_title:Retrovirology

    pub_type: 杂志文章,评审

    doi:10.1186/1742-4690-8-76

    authors: Nair S,Bayer W,Ploquin MJ,Kassiotis G,Hasenkrug KJ,Dittmer U

    更新日期:2011-09-26 00:00:00